The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis
Abstract
INTRODUCTION: Preoperative portal vein embolization (PVE) is used clinically to prevent postoperative liver insufficiency. The current study examined the impact of portal vein embolization on liver resection. METHOD: A comprehensive Medline search to identify all registered literature in the English language on portal vein embolization. Meta-analysis was performed to assess the result of PVE and its impact on major liver resection. RESULT: A total of 75 publications met the search criteria but only 37 provided data sufficiently enough for analysis involving 1088 patients. The overall morbidity rate for PVE was 2.2% without mortality. Four weeks following PVE, 85% patients underwent the planned hepatectomy (n = 930). Twenty-three patients had transient liver failure following resection after PVE (2.5%) but 7 patients developed acute liver failure and died (0.8%). The reason for nonresection following PVE (n = 158, 15%) included inadequate hypertrophy of remnant liver (n = 18), severe progression of liver metastasis (n = 43), extrahepatic spread (n = 35), refusal to surgery (n = 1), poor general condition (n = 1), altered treatment to transcatheter artery embolization or chemotherapy (n = 24), complete remission after treatment with 3 cycles of fluoracil and interferon alpha in a patient with hepatocellular carcinoma (n = 1), incomplete pre- or postembolization scanning (n = 8). Of those who underwent laparotomy without resection, (n = 27) reasons included intraoperative finding of peritoneal dissemination (n = 15), portal node metastasis (n = 2), severe invasion of the tumor to the hepatic artery and portal vein (n = 1), and gross tumoral extension precluding curative resection (n = 9). Two techniques were used for portal vein embolization: percutaneous transhepatic portal embolization, (PTPE) and transileocolic portal embolization, (TIPE). The increase in remnant liver volume was much greater in PTPE than TIPE group (11.9% vs. 9.7%; P = 0.00001). However, the proportion of patients who underwent resection following PVE was 97% in TIPE and 88% PTPE, respectively (P = <0.00001). Although there was no significant difference in patients who had major complications post-PVE, the rate for minor complications was significantly higher among patients who had PTPE (53.6% vs. 0%, P = <0.0001). CONCLUSION: PVE is a safe and effective procedure in inducing liver hypertrophy to prevent postresection liver failure due to insufficient liver remnant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Proposed classification of complications of surgery with examples of utility in cholecystectomy.
Clavien, P., Sanabria, J. R., & Strasberg, S. M. (1992) · PubMed · Cited by 1,952
MAKUUCHI, M., Thai, B. L., Takayasu, K., Takayama, T., Kosuge, T., Gunvén, P., Yamazaki, S., Hasegawa, H., & Ozaki, H. (1990) · PubMed · Cited by 1,120
Kubota, K., Makuuchi, M., Kusaka, K., Kobayashi, T., Miki, K., Hasegawa, K., Harihara, Y., & Takayama, T. (1997) · Hepatology · doi:10.1002/hep.510260514 · Cited by 730
Vauthey, J.-N., Chaoui, A., Do, K.-A., Bilimoria, M. M., Fenstermacher, M. J., Charnsangavej, C., Hicks, M., Alsfasser, G., Lauwers, G., Hawkins, I. F., et al. (2000) · Surgery · doi:10.1067/msy.2000.105294 · Cited by 697
Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial
Farges, O., Belghiti, J., Kianmanesh, R., Marc Regimbeau, J., Santoro, R., Vilgrain, V., Denys, A., & Sauvanet, A. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000048447.16651.7b · Cited by 676
Azoulay, D., Castaing, D., Smail, A., Adam, R., Cailliez, V., Laurent, A., Lemoine, A., & Bismuth, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00005 · Cited by 539
Abdalla, E. K. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.6.675 · Cited by 489
Preoperative portal vein embolization for hepatocellular carcinoma
Kinoshita, H., Sakai, K., Hirohashi, K., Igawa, S., Yamasaki, O., & Kubo, S. (1986) · World Journal of Surgery · doi:10.1007/bf01655244 · Cited by 452
Preoperative Portal Vein Embolization: An Audit of 84 Patients
Imamura, H., Shimada, R., Kubota, M., Matsuyama, Y., Nakayama, A., Miyagawa, S.-I., Makuuchi, M., & Kawasaki, S. (1999) · Hepatology · doi:10.1002/hep.510290415 · Cited by 367
Kokudo, N., Tada, K., Seki, M., Ohta, H., Azekura, K., Ueno, M., Ohta, K., Yamaguchi, T., Matsubara, T., Takahashi, T., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.26513 · Cited by 339
Bringing it all together: Lancet-Cochrane collaborate on systematic reviews
Clarke, M., & Horton, R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04934-5 · Cited by 302
Preoperative Portal Vein Embolization for Extension of Hepatectomy Indications
de Baere, T., Roche, A., Elias, D., Lasser, P., Lagrange, C., & Bousson, V (1996) · Hepatology · doi:10.1002/hep.510240612 · Cited by 290
Madoff, D. C., Hicks, M. E., Abdalla, E. K., Morris, J. S., & Vauthey, J.-N. (2003) · Radiology · doi:10.1148/radiol.2271012010 · Cited by 194
Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery.
de Baere, T., Roche, A., Vavasseur, D., Therasse, E., Indushekar, S., Elias, D., & Bognel, C. (1993) · Radiology · doi:10.1148/radiology.188.1.8511321 · Cited by 186
Uesaka, K., Nimura, Y., & Nagino, M. (1996) · Annals of Surgery · doi:10.1097/00000658-199601000-00011 · Cited by 172
Egger, M., & Smith, G. D. (1995) · BMJ · doi:10.1136/bmj.311.7007.753c · Cited by 151
Hirai, I., Kimura, W., Fuse, A., Suto, K., & Urayama, M. (2003) · Surgery · doi:10.1067/msy.2003.138 · Cited by 102
Eliasson, T., Mannheimer, C., Waagstein, F., Andersson, B., Bergh, C., Augustinsson, L.-E., Hedner, T., & Larson, G. (1998) · Cardiology · doi:10.1159/000006783 · Cited by 96
Wakabayashi, H., Ishimura, K., Okano, K., Karasawa, Y., Goda, F., Maeba, T., & Maeta, H. (2002) · Surgery · doi:10.1067/msy.2002.118259 · Cited by 85
Kawai, M., Naruse, K., Komatsu, S., Kobayashi, S., Nagino, M., Nimura, Y., & Sokabe, M. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00171-x · Cited by 82
Comparison of outcome between extended and nonextended liver resections for neoplasms.
Vauthey, J., Baer, H. U., Guastella, T., & Blumgart, L. H. (1993) · PubMed · Cited by 80
Covey, A. M., Tuorto, S., Brody, L. A., Sofocleous, C. T., Schubert, J., von Tengg‐Kobligk, H., Getrajdman, G. I., Schwartz, L. H., Fong, Y., & Brown, K. T. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.04.1593 · Cited by 59
Elias, D. M., Santoro, R., Ouellet, J.-F., Osmak, L., de Baère, T., & Roche, A. (2004) · PubMed · Cited by 53
Integrating pharmacy into the primary care team
Crowe, G. R., Harris, C., Forster, G. E., & Goh, B. T. (1995) · BMJ · doi:10.1136/bmj.311.7007.753 · Cited by 51
Portal embolization relieves persistent jaundice after complete biliary drainage
Ijichi, M., Makuuchi, M., Imamura, H., & Takayama, T. (2001) · Surgery · doi:10.1067/msy.2001.115358 · Cited by 42
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“This approach is associated with a complication rate of 10–20% and occurrence of severe portal hypertension in 1% of cirrhotic patients [191].”
BackgroundRahbari, N. N., Garden, O. J., Padbury, R., Brooke-Smith, M., Crawford, M., Adam, R., Koch, M., Makuuchi, M., Dematteo, R. P., Christophi, C., et al. (2011) · Surgery · doi:10.1016/j.surg.2010.10.001 · Cited by 2,319
Epidemiology and Management of Hepatocellular Carcinoma
Kulik, L., & El-Serag, H. B. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.08.065 · Cited by 1,735
Schnitzbauer, A. A., Lang, S. A., Goessmann, H., Nadalin, S., Baumgart, J., Farkas, S. A., Fichtner-Feigl, S., Lorf, T., Goralcyk, A., Hörbelt, R., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31824856f5 · Cited by 1,332
Hepatocellular carcinoma: a review
Balogh, J., Victor, D., Asham, E. H., Burroughs, S. G., Boktour, M., Saharia, A., Li, X., Ghobrial, M., & Monsour, H. (2016) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s61146 · Cited by 1,185
Metadata
- Authors
- Abulkhir, A., Limongelli, P., Healey, A. J., Damrah, O., Tait, P., Jackson, J., Habib, N., & Jiao, L. R.
- Venue
- Annals of Surgery
- Published
- 2008-01
- Volume
- 247
- Issue
- 1
- Pages
- 49-57
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2071122563
- Cited by
- 673
- References
- 28
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.